Chinese
Home
About Livzon
Milestones
Leaders' Caring
Company Honors
Cultural Vision
Contact Us
Media
Livzon News
Employment system
Investor Relations
Company Governance
Announcement
Financial Reports
ESG Report
Shareholder Returns
Stock Information
Sustainable Development
Human Development
Board Diversity Policy
Business Ethics
Supplier
Environment, Occupational Health and Safety (EHS)
Philanthropy
Privacy Policy
Tax policy
ESG Ratings and Honors
Product
Leading Products
Products List
ADR Reporting
R&D
R&D Platforms
Livzon microspheres
Livzon Bio
Livzon Research Institute
R&D Achievements
IP Achievements
Overseas Market
Overseas Business
Specialty Products
Certificates
Contact us
Join Us
Social Recruitment
Campus Recruitment
Compensation and Benefits
Appeal Against
Bidding procurement
Tender Announcement
Supplier Login
Supervision and Reporting
Contact information
Online message
ESG report
Shareholder returns
Stock information
Contacts
2026
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Next Day Disclosure Return
File size:
87.8KB
File Type:
pdf
2021-12-13
85.6KB
2021-12-10
POLL RESULTS OF THE 2021 FOURTH EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, 10 DECEMBER 2021
181.6KB
86.3KB
2021-12-08
87.9KB
2021-12-07
2021-12-06
REPURCHASE OF H SHARES
120.8KB
INSIDE INFORMATION ILAPRAZOLE SODIUM FOR INJECTION, THE COMPANY'S PRODUCT, CONTINUES TO BE INCLUDED IN THE NATIONAL MEDICAL INSU
156.6KB
2021-12-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
27.7KB
2021-12-02
ANNOUNCEMENT ON THE COMMENCEMENT OF THE THIRD EXERCISE PERIOD UNDER THE FIRST GRANT AND THE SECOND EXERCISE PERIOD UNDER THE RES
127.8KB
2021-11-26
